Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.

Consensus $7.86. The company said, “The company raised its fiscal 2025 guidance range for non-GAAP diluted earnings per share attributable to ...

Cardinal Health Inc (NYSE:CAH). shares have reached an unprecedented peak, with the stock hitting an all-time high of $130.1.

Jan 14 (Reuters) - Cardinal Health (CAH.N), opens new tab said on Tuesday it expects annual profit to be at the higher end of its previous forecast range, primarily driven by strong demand for ...

Cardinal Health Inc. raised its earnings outlook for fiscal 2025 for the second time in the first half of the year.  Ahead of CEO Jason ...

Leerink Partners analyst Michael Cherny has maintained their bullish stance on CAH stock, giving a Buy rating on January 15.Stay Ahead of the ...

Clemson was very efficient against the Cardinal, shooting over 40 percent from the field and 3-point range. Winning the 3-point line has been key for the Tigers all season, and it was a massive ...